Tumours associated with BAP1 mutations
References (88)
- et al.
Defining the human deubiquitinating enzyme interaction landscape
Cell
(2009) - et al.
The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1
J Biol Chem
(2009) - et al.
E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases
Mol Cell
(2007) - et al.
Control of alpha-herpesvirus IE gene expression by HCF-1 coupled chromatin modification activities
Biochim Biophys Acta
(2010) - et al.
A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation
Mol Cell
(2007) - et al.
Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation
Dev Cell
(2004) - et al.
Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing
Biochem Biophys Res Commun
(2007) - et al.
Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells
J Biol Chem
(2006) Cancer susceptibility and the functions of BRCA1 and BRCA2
Cell
(2002)- et al.
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
J Biol Chem
(2001)
Lack of BRAF mutations in Spitz nevi
J Invest Dermatol
(2004)
Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma
Pathology
(2004)
Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome
Hum Pathol
(1999)
Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features
Am J Pathol
(2000)
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
Oncogene
(1998)
Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease
Brief Funct Genomic Proteomic
(2007)
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma
Nat Genet
(2011)
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization
Cancer Res
(2008)
Frequent mutation ofBAP1 in metastasizing uveal melanomas
Science
(2010)
Mutation and cancer: statistical study of retinoblastoma
Proc Natl Acad Sci USA
(1971)
BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity
Cancer Res
(2009)
Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1
Mol Cell Biol
(2009)
An emerging model for BAP1’s role in regulating cell cycle progression
Cell Biochem Biophys
(2011)
The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection
Proc Natl Acad Sci USA
(2007)
The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression
Mol Cell Biol
(2010)
Polycomb group proteins in the DNA damage response: a link between radiation resistance and ‘stem-ness’
Cell Cycle
(2011)
Role of histone H2A ubiquitination in Polycomb silencing
Nature
(2004)
Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
Nature
(2010)
The Polycomb group protein EZH2 directly controls DNA methylation
Nature
(2006)
Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island
PLoS Genet
(2008)
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes
Genes Dev
(2006)
Rauscher FJ 3rd. BAP1, a candidate tumor suppressor protein that interacts with BRCA1
Ann NY Acad Sci
(1999)
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
EMBO J
(2002)
Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
Cancer Sci
(2012)
New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment
Clin Cancer Res
(2012)
A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression
Am J Surg Pathol
(2012)
Germline mutations in BAP1 predispose to melanocytic tumors
Nat Genet
(2011)
BAP1 loss defines a new class of renal cell carcinoma
Nat Genet
(2012)
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, menin-gioma, and other cancers
J Med Genet
(2011)
A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma
Pigment Cell Melanoma Res
(2012)
Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma
Anticancer Res
(2004)
The T1796A mutation of the BRAF gene is absent in Spitz nevi
J Cutan Pathol
(2004)
The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution
Cancer
(2009)
Cited by (225)
Beyond typical histology of BAP1-inactivated melanocytoma
2024, Pathology Research and PracticeThe cytologic diagnosis of mesothelioma: are we there yet?
2023, Journal of the American Society of CytopathologyMolecular pathology and testing in melanocytic tumors
2023, Diagnostic Molecular Pathology: A Guide to Applied Molecular Testing, Second EditionMalignant and borderline mesothelial tumors of the pleura
2022, Practical Pulmonary Pathology: A Diagnostic Approach
Copyright © 2013 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.